China Health Technology Group (1069) Fair Value & Analysis
Basic Materials · HK · Market cap HK$39.7M
Fair value as of: Aug 13, 2026
From 9 valuation models · updated 2 days ago
Below-average quality, and screening another 52% overvalued on our models.
What matters now
- Weak quality (31/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The model range is unusually wide (HK$0.0888 to HK$0.5314). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range HK$0.2260 – HK$18.45 · fair‑value band HK$0.0888 – HK$0.5314 · the HK$0.2850 price screens above the HK$0.1360 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
China Health Technology Group (1069) currently trades at HK$0.2850, while our model-based Fair Value estimate is HK$0.1360, implying the stock looks roughly 52.3% overvalued today. The Quality Score stands at 31/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, China Health Technology Group generated revenue of HK$93.5M at a net margin of 24.6%. Revenue grew 10.5% year over year. It earns a return on equity of 56.2%. Net debt stands at HK$112M. Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$0.0888 (bear case) to HK$0.5314 (bull case); at HK$0.2850, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 45% below its 52-week high and 40% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -39% fair-value upside, at -52%, 1069 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: Growth Earnings (HK$5.73) versus Asset-Based (HK$0.2400). Highest evidence: Growth-Adj P/E (68).
Notify me when 1069 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 33 · Market factors (momentum, volatility) 27
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
China Health Technology Group Holding Company Limited, an investment holding company, engages in the forestry management business in the People's Republic of China. The company operates through Forestry Business, Ginseng Business, and Horny Goat Weed Business segments.
Full company description
China Health Technology Group Holding Company Limited, an investment holding company, engages in the forestry management business in the People's Republic of China. The company operates through Forestry Business, Ginseng Business, and Horny Goat Weed Business segments. The Forestry Business segment engages in the plantation, logging, and sale of timber related products. The Ginseng Business segment is involved in the ginseng plantation and trading of related products. The Horny Goat Weed Business segment engages in the horny goat weed plantation and trading of related products. The company was formerly known as China Bozza Development Holdings Limited and changed its name to China Health Technology Group Holding Company Limited in December 2023. China Health Technology Group Holding Company Limited was incorporated in 2009 and is headquartered in Shenzhen, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
China Health Technology Group reported revenue of HK$97.3M in FY2025 versus HK$6.8M in FY2021, a compound +94.8%/yr. Reported net income was HK$24.2M in FY2025.
1069 screens 52% overvalued. Compare with Simpson Manufacturing Co →
Peer Group
Lumber & Wood Production · 79 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Lumber & Wood Production median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Lumber & Wood Production stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Simpson Manufacturing Co SSD | $194.83 | $145.26 | -25% |
| West Fraser Timber Co WFG | C$97.70 | C$33.38 | -66% |
| UFP Industries, Inc UFPI | $92.82 | $107.07 | +15% |
| Stella-Jones Inc SJ | C$75.22 | C$92.56 | +23% |
| Boise Cascade Company BCC | $84.25 | $51.39 | -39% |
| Century Plyboards (India) Limited CENTURYPLY | ₹763.85 | ₹201.01 | -74% |
| DeHua TB New Decoration Material Co 002043 | ¥12.58 | ¥14.78 | +17% |
| Canfor Corporation CFP | C$15.73 | C$4.54 | -71% |
| Interfor Corporation IFP | C$14.38 | C$6.43 | -55% |
| Kangxin New Materials Co 600076 | ¥3.17 | ¥0.6700 | -79% |
Compare China Health Technology Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is China Health Technology Group (1069) overvalued or undervalued?
What is the fair value of 1069?
What is the quality score of 1069?
What is the revenue of China Health Technology Group (1069)?
What is the net profit margin of 1069?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track China Health Technology Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.